Atlas Trials

Therapeutic Efficacy and Safety of Non-Invasive RF Treatment in Refractory MGD

Clinical trial NCT06220474 · RECRUITING

Trial details

NCT number
NCT06220474
Sponsor
The University of Hong Kong
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Dry Eye SyndromesMeibomian Gland Dysfunction
Start date
2024-10-22
Primary completion
2027-10-30
Enrollment
112

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.